Pricing Log in Create free account

Inovio Pharmaceuticals, Inc. (INO) vs vTv Therapeutics Inc. (VTVT)

Inovio Pharmaceuticals, Inc. and vTv Therapeutics Inc. are both Biotechnology companies. Inovio Pharmaceuticals, Inc. and vTv Therapeutics Inc. are of similar size ($109.1M and $107.5M). vTv Therapeutics Inc. grew revenue faster over the last twelve months: 654.6% against −54.8%. Across the 13 metrics below, vTv Therapeutics Inc. leads on 10 and Inovio Pharmaceuticals, Inc. on 3.

Valuation

Metric INO VTVT Biotechnology median
P/E n/m n/m 8.50
P/S 209.44 8.71 9.71
P/B 18.49 4.19 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 157.45 6.46 9.21
Earnings yield (91.92%) (2.90%) (33.15%)
Free cash flow yield (99.09%) (5.11%) (25.50%)

Profitability

Metric INO VTVT Biotechnology median
Gross margin 100.00% 99.92% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (409.87%) (11.74%) (56.36%)
Return on assets (114.64%) (8.34%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INO VTVT Biotechnology median
Revenue growth (TTM) (54.82%) 654.58% 6.02%
EPS growth (last fiscal year) 54.18% 0.00% 30.26%
Revenue growth, 5-year CAGR (61.18%) (39.39%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INO VTVT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.00 12.48 4.72
Net debt to EBITDA 0.70 2.71 0.96

Dividend

Metric INO VTVT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric INO VTVT Biotechnology median
Market cap 107.53m 109.09m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack